TransMedics Group (TMDX) Reiterated at Hold by Stifel Post ATC Meeting
Tweet Send to a Friend
Stifel analyst Thomas Stephan reiterated a Hold rating and $80.00 price target on TransMedics Group (NASDAQ: TMDX).The analyst commented, "This ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


